← All news

FROM THE NEWS FEED

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026

2026-08-14 • Psychedelic Invest

Article summary

CAMBRIDGE, Mass., August 14, 2026--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address…

Continue to the original publication for the complete article.